Natera Inc (NAS:NTRA)
$ 162.39 0.4 (0.25%) Market Cap: 21.44 Bil Enterprise Value: 20.99 Bil PE Ratio: 0 PB Ratio: 22.95 GF Score: 70/100

Natera Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 18, 2020 / 07:50PM GMT
Release Date Price: $45.93 (+1.55%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Great. Welcome. This is Dan Brennan. I cover tools, diagnostics, pharma services here at UBS. Day 1 of our virtual conference. So thanks for anyone on the phone or on the webcast participating. Really pleased to be joined with me -- on the phone with the Chief Financial Officer of Natera, Mike Brophy. Mike and I actually go way back, having overlapped at a predecessor broker firm before Mike went on to greener pastures at Natera.

So Mike, welcome, and thanks for being with us.

Michael Brophy
Natera, Inc. - CFO

Thanks, Dan. It's good to be with you.

Questions & Answers

Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Awesome. Well, feel free, anyone on the phone, to punch in some questions into the webcast. I will do my best. And we've gotten 1 or 2 each presentation, certainly, will do my best to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot